 Profile
| A demonstrated leader in the pharmaceutical and healthcare industries, Mr. Richard Trevillion currently leverages his nearly twenty years of experience toward his position as Managing Director and CEO of Amity Partners, a corporate consulting firm he founded in 2001. Specializing in financial management, Richard Trevillion excels in negotiating mergers, acquisitions, and strategic restructurings. In his capacity as CEO, Richard Trevillion has spearheaded a number of impressive turnarounds for major pharmaceutical companies from throughout the United Kingdom and the rest of Europe. Outside of his leadership of Amity Partners, Richard Trevillion recently held the position of CEO for Meldex International PLC. Richard Trevillion joined the company in April 2005 as Interim CEO and remained as the fulltime CEO from May 2005 to September 2008. When Richard Trevillion joined Meldex International, the company was operating under the name BioProgress. Despite its strong potential and impressive technological offerings, BioProgress was burning funds rapidly and suffering from severe operational mismanagement. Under Mr. Trevillion’s guidance, the company was successfully restructured into an integrated specialty pharmaceuticals firm with steady annual revenues, a large and diverse product suite, and an increased presence in the global market. Richard Trevillion also initiated several successful partnerships with other prominent firms and expanded the company’s overall scope through acquisitions and mergers. A licensed solicitor, Richard Trevillion started his professional career with the law firm of Lovell White Durrant. After completing his practical legal training with Lovell White Durrant, Richard Trevillion joined Simmons & Simmons International Finance and Capital Markets Group where he was in charge of managing a variety of commercial finance projects. In Richard Trevillion’s next position, he served as a Manager for Coopers & Lybrand Corporate Finance. Richard Trevillion carried his experience into his next role as Co-Director of the Healthcare Corporate Finance team at Arthur Andersen from 1997 to 2000. Immediately prior to establishing Amity Partners, Richard Trevillion served as Director of the Healthcare and Life Science Corporate Finance Team at Close Brothers Corporate.
|
|
